Pharmaron Beijing Co., Ltd.

SEHK:3759 Voorraadrapport

Marktkapitalisatie: HK$51.2b

Pharmaron Beijing Beheer

Beheer criteriumcontroles 4/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Boliang Lou

Algemeen directeur

CN¥2.2m

Totale compensatie

Percentage CEO-salaris95.1%
Dienstverband CEO8.1yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn8.1yrs
Gemiddelde ambtstermijn bestuur8.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Boliang Lou's beloning veranderd ten opzichte van Pharmaron Beijing's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

CN¥2b

Jun 30 2024n/an/a

CN¥2b

Mar 31 2024n/an/a

CN¥1b

Dec 31 2023CN¥2mCN¥2m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥1b

Jan 01 2023n/an/a

CN¥1b

Sep 30 2022n/an/a

CN¥2b

Jun 30 2022n/an/a

CN¥2b

Mar 31 2022n/an/a

CN¥2b

Dec 31 2021CN¥8mCN¥2m

CN¥2b

Sep 30 2021n/an/a

CN¥1b

Jun 30 2021n/an/a

CN¥1b

Mar 31 2021n/an/a

CN¥1b

Dec 31 2020CN¥4mCN¥2m

CN¥1b

Sep 30 2020n/an/a

CN¥1b

Jun 30 2020n/an/a

CN¥865m

Mar 31 2020n/an/a

CN¥594m

Dec 31 2019CN¥3mCN¥2m

CN¥547m

Sep 30 2019n/an/a

CN¥437m

Jun 30 2019n/an/a

CN¥378m

Mar 31 2019n/an/a

CN¥346m

Dec 31 2018CN¥3mCN¥2m

CN¥333m

Compensatie versus markt: Boliang's total compensation ($USD311.40K) is below average for companies of similar size in the Hong Kong market ($USD640.18K).

Compensatie versus inkomsten: Boliang's compensation has been consistent with company performance over the past year.

CEO

Boliang Lou (61 yo)

8.1yrs

Tenure

CN¥2,208,000

Compensatie

Dr. Boliang Lou, Ph D serves as Chairman of the Board and Chief Executive Officer at Pharmaron, Inc. He is a Co-Founder at Pharmaron, Inc. Dr. Lou serves as the Chairman, Chief Executive Officer and Manage...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Boliang Lou
Chairman & CEOno dataCN¥2.21mgeen gegevens
Xiaoqiang Lou
Co-Founder8.1yrsCN¥1.91m5.66%
HK$ 2.9b
Bei Zheng
Executive VP & Executive Director8.1yrsCN¥1.60m2.12%
HK$ 1.1b
Shing Chung Li
CFO & Secretary of the Boardno dataCN¥1.96mgeen gegevens
Hua Yang
Chief Scientific Officer & Deputy Manager8.1yrsCN¥1.85mgeen gegevens
Connie Sun
Senior VP & Global Head of Business Development of Small Moleculesno datageen gegevensgeen gegevens
Celina Zhong
Senior Vice President of Human Resourcesno datageen gegevensgeen gegevens
Katherine Lee
Chief Business Officer13.8yrsgeen gegevensgeen gegevens
Stephen Lewinton
Senior Vice President of UK Operationsno datageen gegevensgeen gegevens
Jingqi Huang
Senior Vice President of In Vivo Pharmacologyno datageen gegevensgeen gegevens
Mandy Xu
Senior Vice President of DMPK2.9yrsgeen gegevensgeen gegevens
Sid Bhoopathy
Senior VP and US Head of Laboratory Services & CGT3yrsgeen gegevensgeen gegevens

8.1yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: 3759's management team is seasoned and experienced (8.1 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Boliang Lou
Chairman & CEO8.1yrsCN¥2.21mgeen gegevens
Xiaoqiang Lou
Co-Founder8.1yrsCN¥1.91m5.66%
HK$ 2.9b
Bei Zheng
Executive VP & Executive Director8.1yrsCN¥1.60m2.12%
HK$ 1.1b
Kexin Yang
Chairman of the Supervisory Committee8.1yrsgeen gegevensgeen gegevens
Jiaqing Li
Non Executive Director8.1yrsgeen gegevensgeen gegevens
Kwan Hung Tsang
Independent Non Executive Director5yrsCN¥300.00kgeen gegevens
Lan Zhang
Employee Representative Supervisor8.1yrsgeen gegevensgeen gegevens
Lihua Li
Independent Non Executive Director2.2yrsCN¥300.00k0.0042%
HK$ 2.2m
Jian Yu
Independent Non Executive Director4.3yrsCN¥300.00kgeen gegevens
Shu Feng
Supervisor3.9yrsgeen gegevensgeen gegevens
Qilin Zhou
Independent Non-Executive Director2.2yrsCN¥300.00kgeen gegevens

8.1yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: 3759's board of directors are considered experienced (8.1 years average tenure).